Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis

Abstract

We report a case of an infected massive endoprosthetic replacement treated successfully with 2 stage surgery and off-label dalbavancin. Dalbavancin was used due to a limited number of antimicrobial options that could be administered safely in an outpatient setting and to avoid the need for daily dosing.